AUTHENTIDATE HOLDING CORPORATION (OTCMKTS:ADAT) Shorted Shares Increased 1.4% After Market Selling

October 12, 2017 - By Kurt Siggers

The stock of AUTHENTIDATE HOLDING CORPORATION (OTCMKTS:ADAT) registered an increase of 1.4% in short interest. ADAT’s total short interest was 14,500 shares in October as published by FINRA. Its up 1.4% from 14,300 shares, reported previously. With 9,800 shares average volume, it will take short sellers 2 days to cover their ADAT’s short positions.

It is 0.00% or $0 reaching $1.38 per share. It is down 0.00% since October 12, 2016 and is . It has underperformed by 16.70% the S&P500.

Authentidate Holding Corp. and its subsidiaries provide Web revenue cycle management applications, and telehealth services and products. The company has market cap of $10.00 million. The Firm enables healthcare organizations to coordinate care for patients and to manage related administrative and clinical workflows. It currently has negative earnings. The Company’s Web solutions incorporate multiple features and security technologies, such as business-rules based electronic forms, intelligent routing, transaction management, electronic signatures, identity credentialing, content authentication, automated audit trails and remote patient management capabilities.

More notable recent Authentidate Holding Corp. (OTCMKTS:ADAT) news were published by: which released: “Authentidate and AEON Clinical Laboratories Complete Merger to Form Innovative …” on January 28, 2016, also with their article: “AEON Clinical Laboratory Partners With Authentidate’s HIPAA-Compliant …” published on September 04, 2015, published: “Aeon Global Health, Operating Arm of Authentidate Holding Corp., Names David C …” on September 11, 2017. More interesting news about Authentidate Holding Corp. (OTCMKTS:ADAT) were released by: and their article: “Authentidate Holding Corp.” published on August 15, 2003 as well as‘s news article titled: “1.41” with publication date: December 21, 2009.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.